Last Price Today's Change   Day's Range   Trading Volume
0.015   -0.001 (6.25%)  0.015 - 0.017  2,156,340


Avg Volume (4 weeks):1,234,873
4 Weeks Range:0.015 - 0.022
4 Weeks Price Volatility (%):
52 Weeks Range:0.012 - 0.049
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Invion Limited is a clinical-stage life sciences (drug development) company. The Company is engaged in the completion of clinical development programs and targeted business development programs associated with its approximately three drug assets, such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast). It focuses on the development of treatments for opportunities in chronic inflammatory and respiratory disease. INV102 (nadolol) is a beta adrenergic biased ligand targeted to treat chronic inflammatory airway diseases via the reversal of mucous metaplasia in the airway epithelium. INV104 (zafirlukast) is a leukotriene receptor antagonist (LTRA) that reduces inflammation, constriction of the airways, and the build-up of mucus in the lungs. INV103 (ala-Cpn10) is a modified, naturally occurring human protein, which has been proposed as a founding member of the Resolution Associated Molecular Pattern (RAMPs) family hypothesized to maintain and restore immune homeostasis.

  Be the first to like this.


554  664  655  9294 

Top 10 Active Counters
 ADN 0.009-0.001 
 CLA 0.03+0.006 
 RFX 0.047+0.008 
 QGL 0.002-0.001 
 CML 0.035-0.007 
 VML 0.010.00 
 TLS 3.56+0.05 
 FMG 8.95+0.55 
 GMC 0.006-0.001 
 SBM 2.91-0.41 
Partners & Brokers